SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro
SARS-CoV-2 infection can cause fatal inflammatory lung pathology, including thrombosis and increased pulmonary vascular permeability leading to edema and hemorrhage. In addition to the lung, cytokine storm-induced inflammatory cascade also affects other organs. SARS-CoV-2 infection-related vascular...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2021.701278/full |
id |
doaj-e2de576c347c428db861b40e4ee8c99f |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Fengming Liu Fengming Liu Kun Han Robert Blair Kornelia Kenst Zhongnan Qin Berin Upcin Philipp Wörsdörfer Cecily C. Midkiff Joseph Mudd Elizaveta Belyaeva Nicholas S. Milligan Tyler D. Rorison Nicole Wagner Jochen Bodem Lars Dölken Bertal H. Aktas Richard S. Vander Heide Xiao-Ming Yin Jay K. Kolls Chad J. Roy Chad J. Roy Jay Rappaport Jay Rappaport Süleyman Ergün Xuebin Qin Xuebin Qin |
spellingShingle |
Fengming Liu Fengming Liu Kun Han Robert Blair Kornelia Kenst Zhongnan Qin Berin Upcin Philipp Wörsdörfer Cecily C. Midkiff Joseph Mudd Elizaveta Belyaeva Nicholas S. Milligan Tyler D. Rorison Nicole Wagner Jochen Bodem Lars Dölken Bertal H. Aktas Richard S. Vander Heide Xiao-Ming Yin Jay K. Kolls Chad J. Roy Chad J. Roy Jay Rappaport Jay Rappaport Süleyman Ergün Xuebin Qin Xuebin Qin SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro Frontiers in Cellular and Infection Microbiology endothelial cell infection animal models SARS-CoV-2 aorta ring hACE2 |
author_facet |
Fengming Liu Fengming Liu Kun Han Robert Blair Kornelia Kenst Zhongnan Qin Berin Upcin Philipp Wörsdörfer Cecily C. Midkiff Joseph Mudd Elizaveta Belyaeva Nicholas S. Milligan Tyler D. Rorison Nicole Wagner Jochen Bodem Lars Dölken Bertal H. Aktas Richard S. Vander Heide Xiao-Ming Yin Jay K. Kolls Chad J. Roy Chad J. Roy Jay Rappaport Jay Rappaport Süleyman Ergün Xuebin Qin Xuebin Qin |
author_sort |
Fengming Liu |
title |
SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro |
title_short |
SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro |
title_full |
SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro |
title_fullStr |
SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro |
title_full_unstemmed |
SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro |
title_sort |
sars-cov-2 infects endothelial cells in vivo and in vitro |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Cellular and Infection Microbiology |
issn |
2235-2988 |
publishDate |
2021-07-01 |
description |
SARS-CoV-2 infection can cause fatal inflammatory lung pathology, including thrombosis and increased pulmonary vascular permeability leading to edema and hemorrhage. In addition to the lung, cytokine storm-induced inflammatory cascade also affects other organs. SARS-CoV-2 infection-related vascular inflammation is characterized by endotheliopathy in the lung and other organs. Whether SARS-CoV-2 causes endotheliopathy by directly infecting endothelial cells is not known and is the focus of the present study. We observed 1) the co-localization of SARS-CoV-2 with the endothelial cell marker CD31 in the lungs of SARS-CoV-2-infected mice expressing hACE2 in the lung by intranasal delivery of adenovirus 5-hACE2 (Ad5-hACE2 mice) and non-human primates at both the protein and RNA levels, and 2) SARS-CoV-2 proteins in endothelial cells by immunogold labeling and electron microscopic analysis. We also detected the co-localization of SARS-CoV-2 with CD31 in autopsied lung tissue obtained from patients who died from severe COVID-19. Comparative analysis of RNA sequencing data of the lungs of infected Ad5-hACE2 and Ad5-empty (control) mice revealed upregulated KRAS signaling pathway, a well-known pathway for cellular activation and dysfunction. Further, we showed that SARS-CoV-2 directly infects mature mouse aortic endothelial cells (AoECs) that were activated by performing an aortic sprouting assay prior to exposure to SARS-CoV-2. This was demonstrated by co-localization of SARS-CoV-2 and CD34 by immunostaining and detection of viral particles in electron microscopic studies. Moreover, the activated AoECs became positive for ACE-2 but not quiescent AoECs. Together, our results indicate that in addition to pneumocytes, SARS-CoV-2 also directly infects mature vascular endothelial cells in vivo and ex vivo, which may contribute to cardiovascular complications in SARS-CoV-2 infection, including multipleorgan failure. |
topic |
endothelial cell infection animal models SARS-CoV-2 aorta ring hACE2 |
url |
https://www.frontiersin.org/articles/10.3389/fcimb.2021.701278/full |
work_keys_str_mv |
AT fengmingliu sarscov2infectsendothelialcellsinvivoandinvitro AT fengmingliu sarscov2infectsendothelialcellsinvivoandinvitro AT kunhan sarscov2infectsendothelialcellsinvivoandinvitro AT robertblair sarscov2infectsendothelialcellsinvivoandinvitro AT korneliakenst sarscov2infectsendothelialcellsinvivoandinvitro AT zhongnanqin sarscov2infectsendothelialcellsinvivoandinvitro AT berinupcin sarscov2infectsendothelialcellsinvivoandinvitro AT philippworsdorfer sarscov2infectsendothelialcellsinvivoandinvitro AT cecilycmidkiff sarscov2infectsendothelialcellsinvivoandinvitro AT josephmudd sarscov2infectsendothelialcellsinvivoandinvitro AT elizavetabelyaeva sarscov2infectsendothelialcellsinvivoandinvitro AT nicholassmilligan sarscov2infectsendothelialcellsinvivoandinvitro AT tylerdrorison sarscov2infectsendothelialcellsinvivoandinvitro AT nicolewagner sarscov2infectsendothelialcellsinvivoandinvitro AT jochenbodem sarscov2infectsendothelialcellsinvivoandinvitro AT larsdolken sarscov2infectsendothelialcellsinvivoandinvitro AT bertalhaktas sarscov2infectsendothelialcellsinvivoandinvitro AT richardsvanderheide sarscov2infectsendothelialcellsinvivoandinvitro AT xiaomingyin sarscov2infectsendothelialcellsinvivoandinvitro AT jaykkolls sarscov2infectsendothelialcellsinvivoandinvitro AT chadjroy sarscov2infectsendothelialcellsinvivoandinvitro AT chadjroy sarscov2infectsendothelialcellsinvivoandinvitro AT jayrappaport sarscov2infectsendothelialcellsinvivoandinvitro AT jayrappaport sarscov2infectsendothelialcellsinvivoandinvitro AT suleymanergun sarscov2infectsendothelialcellsinvivoandinvitro AT xuebinqin sarscov2infectsendothelialcellsinvivoandinvitro AT xuebinqin sarscov2infectsendothelialcellsinvivoandinvitro |
_version_ |
1721317254189023232 |
spelling |
doaj-e2de576c347c428db861b40e4ee8c99f2021-07-06T14:30:57ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882021-07-011110.3389/fcimb.2021.701278701278SARS-CoV-2 Infects Endothelial Cells In Vivo and In VitroFengming Liu0Fengming Liu1Kun Han2Robert Blair3Kornelia Kenst4Zhongnan Qin5Berin Upcin6Philipp Wörsdörfer7Cecily C. Midkiff8Joseph Mudd9Elizaveta Belyaeva10Nicholas S. Milligan11Tyler D. Rorison12Nicole Wagner13Jochen Bodem14Lars Dölken15Bertal H. Aktas16Richard S. Vander Heide17Xiao-Ming Yin18Jay K. Kolls19Chad J. Roy20Chad J. Roy21Jay Rappaport22Jay Rappaport23Süleyman Ergün24Xuebin Qin25Xuebin Qin26Division of Comparative Pathology, Tulane National Primate Research Center, Covington, LA, United StatesDepartment of Immunology and Microbiology, Tulane University School of Medicine, New Orleans, LA, United StatesDivision of Comparative Pathology, Tulane National Primate Research Center, Covington, LA, United StatesDivision of Comparative Pathology, Tulane National Primate Research Center, Covington, LA, United StatesInstitute of Anatomy and Cell Biology, Julius-Maximilians-Universität Würzburg, Würzburg, GermanyDivision of Comparative Pathology, Tulane National Primate Research Center, Covington, LA, United StatesInstitute of Anatomy and Cell Biology, Julius-Maximilians-Universität Würzburg, Würzburg, GermanyInstitute of Anatomy and Cell Biology, Julius-Maximilians-Universität Würzburg, Würzburg, GermanyDivision of Comparative Pathology, Tulane National Primate Research Center, Covington, LA, United StatesDivision of Comparative Pathology, Tulane National Primate Research Center, Covington, LA, United StatesDepartment of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA, United StatesDepartment of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA, United StatesDepartment of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA, United StatesInstitute of Anatomy and Cell Biology, Julius-Maximilians-Universität Würzburg, Würzburg, GermanyInstitute of Virology, Julius-Maximilians-Universität Würzburg, Würzburg, GermanyInstitute of Virology, Julius-Maximilians-Universität Würzburg, Würzburg, GermanyDivision of Hematology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, United StatesDepartment of Pathology, LSU Health Sciences Center, New Orleans, LA, United StatesDepartment of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA, United StatesDepartments of Medicine and Pediatrics, Center for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA, United StatesDivision of Comparative Pathology, Tulane National Primate Research Center, Covington, LA, United StatesDepartment of Immunology and Microbiology, Tulane University School of Medicine, New Orleans, LA, United StatesDivision of Comparative Pathology, Tulane National Primate Research Center, Covington, LA, United StatesDepartment of Immunology and Microbiology, Tulane University School of Medicine, New Orleans, LA, United StatesInstitute of Anatomy and Cell Biology, Julius-Maximilians-Universität Würzburg, Würzburg, GermanyDivision of Comparative Pathology, Tulane National Primate Research Center, Covington, LA, United StatesDepartment of Immunology and Microbiology, Tulane University School of Medicine, New Orleans, LA, United StatesSARS-CoV-2 infection can cause fatal inflammatory lung pathology, including thrombosis and increased pulmonary vascular permeability leading to edema and hemorrhage. In addition to the lung, cytokine storm-induced inflammatory cascade also affects other organs. SARS-CoV-2 infection-related vascular inflammation is characterized by endotheliopathy in the lung and other organs. Whether SARS-CoV-2 causes endotheliopathy by directly infecting endothelial cells is not known and is the focus of the present study. We observed 1) the co-localization of SARS-CoV-2 with the endothelial cell marker CD31 in the lungs of SARS-CoV-2-infected mice expressing hACE2 in the lung by intranasal delivery of adenovirus 5-hACE2 (Ad5-hACE2 mice) and non-human primates at both the protein and RNA levels, and 2) SARS-CoV-2 proteins in endothelial cells by immunogold labeling and electron microscopic analysis. We also detected the co-localization of SARS-CoV-2 with CD31 in autopsied lung tissue obtained from patients who died from severe COVID-19. Comparative analysis of RNA sequencing data of the lungs of infected Ad5-hACE2 and Ad5-empty (control) mice revealed upregulated KRAS signaling pathway, a well-known pathway for cellular activation and dysfunction. Further, we showed that SARS-CoV-2 directly infects mature mouse aortic endothelial cells (AoECs) that were activated by performing an aortic sprouting assay prior to exposure to SARS-CoV-2. This was demonstrated by co-localization of SARS-CoV-2 and CD34 by immunostaining and detection of viral particles in electron microscopic studies. Moreover, the activated AoECs became positive for ACE-2 but not quiescent AoECs. Together, our results indicate that in addition to pneumocytes, SARS-CoV-2 also directly infects mature vascular endothelial cells in vivo and ex vivo, which may contribute to cardiovascular complications in SARS-CoV-2 infection, including multipleorgan failure.https://www.frontiersin.org/articles/10.3389/fcimb.2021.701278/fullendothelial cell infectionanimal modelsSARS-CoV-2aorta ringhACE2 |